Results 1 to 10 of about 263 (55)

Inhibition of mammalian RNA polymerase by 5,6-dichlororibofuranosylbenzimidazole (DRB) and DRB triphosphate [PDF]

Nucleic Acids Research, 1978
DRB triphosphate inhibits activity of isolated RNA polymerase B, and, to a lesser extent, that of polymerase A. The same holds true for transcription in isolated nuclei. It does not act as an initiation inhibitor. In all cases, high concentrations of DRB triphosphate are required. Cells do not phosphorylate DRB to a measurable extent.
C, Dreyer, P, Hausen
openaire   +2 more sources

5,6‐dichlororibofuranosylbenzimidazole (DRB) is phosphorylated in salivary gland cells of Chironomus tentans [PDF]

FEBS Letters, 1979
Egyházi, Endre, Shugar, David
openaire   +2 more sources

Kinetic analysis of uptake and phosphorylation of 5,6-dichlororibofuranosylbenzimidazole (DRB) by salivary gland cells of Chironomus tentans.

Journal of Biological Chemistry, 1980
E, Egyházi, A, Ossoinak, M, Holst, K, Rosendahl, U, Tayip   +4 more
openaire   +2 more sources

Population pharmacokinetic modeling and simulation of maribavir to support dose selection and regulatory approval in adolescents with posttransplant refractory cytomegalovirus. [PDF]

CPT Pharmacometrics Syst Pharmacol, 2023
Sun K, Hayes S, Farrell C, Song IH.
europepmc   +1 more source

5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) induces apoptosis in breast cancer cells through inhibiting of Mcl-1 expression. [PDF]

Sci Rep, 2023
Kuo YH, Lai TC, Chang CH, Hsieh HC, Yang FM, Hu MC.   +5 more
europepmc   +1 more source

Maribavir Pharmacokinetics and Safety in Participants With Moderate Hepatic Impairment: A Phase 1, Open-Label, Single-Dose, Parallel Group Study. [PDF]

J Clin Pharmacol, 2023
Song I, Chen G, Wu J, Ilic K.
europepmc   +1 more source

Ganciclovir and maribavir susceptibility phenotypes of cytomegalovirus UL97 ATP binding region mutations detected by expanded genotypic testing. [PDF]

Antiviral Res, 2021
Chou S, Watters M, Sinha R, Kleiboeker S.   +3 more
europepmc   +1 more source

Dual Resistance to Maribavir and Ganciclovir in Transplant Recipients. [PDF]

Viruses
Kleiboeker SB.
europepmc   +1 more source

Evaluating valaciclovir, letermovir, and maribavir safety in first-trimester human placental development. [PDF]

Sci Rep
Atukorala I, de Alwis N, Beard S, Raghavan S, Hannan NJ, Hui L.   +5 more
europepmc   +1 more source

Association Between Cytomegalovirus Viremia Clearance and Post-Solid Organ Transplant Mortality in Patients With Refractory Cytomegalovirus Infection: SOLSTICE Post Hoc Analysis. [PDF]

Transpl Int
Kamar N, Avery RK, Bo T, Gu J, Kumar D, Witzke O.   +5 more
europepmc   +1 more source